Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: Merz Therapeutics GmbH
Chronic Migraine
United States, Austria, Canada, Czechia, Denmark +8 more
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +29 more
Sponsor: argenx
AChR-Ab Seropositive Generalized Myasthenia Gravis · Myasthenia Gravis · MG · gMG
United States, Belgium, Germany, Greece, Italy +3 more
Sponsor: Boehringer Ingelheim
Heart Failure
United States, Argentina, Belgium, Brazil, Bulgaria +24 more
- Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate CancerNot Yet Recruiting
Sponsor: University of Zurich
Prostate Cancer
Germany, Switzerland
Sponsor: Immedica Pharma AB
Arginase I Deficiency · Hyperargininemia
United States, Austria, Canada, France, Germany +2 more
- Study of Bitopertin in Participants With EPP or XLP (APOLLO)Active Not Recruiting
Sponsor: Disc Medicine, Inc
Erythropoietic Protoporphyria (EPP) · X-Linked Protoporphyria (XLP)
United States, Australia, Belgium, Canada, France +7 more
Sponsor: Eli Lilly and Company
Ulcerative Colitis
United States, Austria, Brazil, Canada, China +12 more
Sponsor: Merck Sharp & Dohme LLC
Castration-Resistant Prostatic Cancer · Metastasis
United States, Argentina, Australia, Brazil, Canada +14 more
Sponsor: Boehringer Ingelheim
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
- MS-Related Disability Worsening and Thalamic Volume LossEnrolling By Invitation
Sponsor: Jung Diagnostics GmbH
Multiple Sclerosis, Relapsing-Remitting
Germany
Sponsor: Eli Lilly and Company
Osteoarthritis
United States, Canada, China, Germany, India +3 more
Sponsor: Merck Sharp & Dohme LLC
Colon Adenocarcinoma · Rectal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +24 more
Sponsor: Bristol-Myers Squibb
Plaque Psoriasis
United States, Argentina, Australia, Belgium, Brazil +20 more
Sponsor: Merck Sharp & Dohme LLC
Triple-Negative Breast Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: AstraZeneca
Ovarian Cancer · Lung Adenocarcinoma · Endometrial Cancer · Lung Squamous Cell Carcinoma
United States, Australia, Canada, China, Germany +7 more
Sponsor: Merz Therapeutics GmbH
Episodic Migraine
United States, Austria, Canada, Czechia, Denmark +8 more
- A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3Active Not Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3
United States, Germany, Japan, Spain
Sponsor: AstraZeneca
Biliary Tract Cancer
United States, Australia, Belgium, Brazil, Canada +14 more
Sponsor: Takeda
Myelodysplastic Syndromes
United States, Australia, Brazil, Bulgaria, Canada +21 more
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisRecruiting
Sponsor: argenx
Systemic Sclerosis (SSc)
United States, Argentina, Belgium, Bulgaria, Chile +19 more
Sponsor: Merck Sharp & Dohme LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +42 more
Sponsor: Novartis Pharmaceuticals
Breast Cancer
Belgium, Bulgaria, Canada, Czechia, Denmark +12 more
- A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMDRecruiting
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration
Austria, Czechia, Denmark, France, Germany +8 more
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruiting
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Inflammatory Bowel Diseases · Crohn's Disease
United States, Australia, Austria, Bosnia and Herzegovina, Brazil +23 more